BACKGROUND: When a patient is expected to die, the ideal plan of care focuses on comfort. Prior investigation of application of one institution's end-of-life symptom management order (ESMO) protocol suggested that comfort measures were often instituted too late and sometimes not at all. We studied patient factors associated with missed opportunities for use of an ESMO protocol and protocol adherence in order to identify areas for quality improvement. METHODS: We abstracted the terminal hospitalization medical record for all adult decedents hospitalized for at least 3 days between April 2005 and April 2006 (n = 496) at a university medical center. Detailed information was collected about ESMO use and opiate titration at the end of life. Among patients expected to die, we used multivariate logistic regression to evaluate factors associated with whether patients were placed on the ESMO protocol prior to death. RESULTS: Half of patients who died received ESMO protocol care (n = 248). All had documentation of a do-not-resuscitate (DNR) order (a requirement of the protocol). An opiate drip was used for 95% of patients placed on the ESMO protocol and it was titrated up at least once for 67% of those patients. Patients had a mean of 4 opiate titrations, but for only a mean of 2.2 was a justification documented (symptom documentation is required for each titration per the protocol). In a multivariable regression accounting for other demographic, clinical and provider variables, uninsured patients (risk ratio [RR] 0.25, 95% confidence interval [CI] 0.06-0.62), patients admitted from a nursing home (RR 0.57, 95% CI 0.30-0.99), and patients considered for transplant (RR 0.60, 95% CI 0.40-0.85) were significantly less likely to be placed on the ESMO protocol prior to death. CONCLUSIONS: Evaluation of implementation of a standardized order set can identify areas for quality improvement and missed opportunities for use.
BACKGROUND: When a patient is expected to die, the ideal plan of care focuses on comfort. Prior investigation of application of one institution's end-of-life symptom management order (ESMO) protocol suggested that comfort measures were often instituted too late and sometimes not at all. We studied patient factors associated with missed opportunities for use of an ESMO protocol and protocol adherence in order to identify areas for quality improvement. METHODS: We abstracted the terminal hospitalization medical record for all adult decedents hospitalized for at least 3 days between April 2005 and April 2006 (n = 496) at a university medical center. Detailed information was collected about ESMO use and opiate titration at the end of life. Among patients expected to die, we used multivariate logistic regression to evaluate factors associated with whether patients were placed on the ESMO protocol prior to death. RESULTS: Half of patients who died received ESMO protocol care (n = 248). All had documentation of a do-not-resuscitate (DNR) order (a requirement of the protocol). An opiate drip was used for 95% of patients placed on the ESMO protocol and it was titrated up at least once for 67% of those patients. Patients had a mean of 4 opiate titrations, but for only a mean of 2.2 was a justification documented (symptom documentation is required for each titration per the protocol). In a multivariable regression accounting for other demographic, clinical and provider variables, uninsured patients (risk ratio [RR] 0.25, 95% confidence interval [CI] 0.06-0.62), patients admitted from a nursing home (RR 0.57, 95% CI 0.30-0.99), and patients considered for transplant (RR 0.60, 95% CI 0.40-0.85) were significantly less likely to be placed on the ESMO protocol prior to death. CONCLUSIONS: Evaluation of implementation of a standardized order set can identify areas for quality improvement and missed opportunities for use.
Authors: N S Wenger; R S Phillips; J M Teno; R K Oye; N V Dawson; H Liu; R Califf; P Layde; R Hakim; J Lynn Journal: J Am Geriatr Soc Date: 2000-05 Impact factor: 5.562
Authors: Anne M Walling; Steven M Asch; Karl A Lorenz; Carol P Roth; Tod Barry; Katherine L Kahn; Neil S Wenger Journal: Arch Intern Med Date: 2010-06-28
Authors: Neil S Wenger; David H Solomon; Carol P Roth; Catherine H MacLean; Debra Saliba; Caren J Kamberg; Laurence Z Rubenstein; Roy T Young; Elizabeth M Sloss; Rachel Louie; John Adams; John T Chang; Patricia J Venus; John F Schnelle; Paul G Shekelle Journal: Ann Intern Med Date: 2003-11-04 Impact factor: 25.391
Authors: Deborah Cook; Graeme Rocker; John Marshall; Peter Sjokvist; Peter Dodek; Lauren Griffith; Andreas Freitag; Joseph Varon; Christine Bradley; Mitchell Levy; Simon Finfer; Cindy Hamielec; Joseph McMullin; Bruce Weaver; Stephen Walter; Gordon Guyatt Journal: N Engl J Med Date: 2003-09-18 Impact factor: 91.245
Authors: N S Wenger; R K Oye; P E Bellamy; J Lynn; R S Phillips; N A Desbiens; P Kussin; S J Youngner Journal: J Gen Intern Med Date: 1994-10 Impact factor: 5.128
Authors: Joan M Teno; Brian R Clarridge; Virginia Casey; Lisa C Welch; Terrie Wetle; Renee Shield; Vincent Mor Journal: JAMA Date: 2004-01-07 Impact factor: 56.272
Authors: Howard L Saft; Paul S Richman; Andrew R Berman; Richard A Mularski; Paul A Kvale; Daniel E Ray; Paul Selecky; Dee W Ford; Steven M Asch Journal: J Grad Med Educ Date: 2014-03
Authors: F Amos Bailey; Beverly R Williams; Lesa L Woodby; Patricia S Goode; David T Redden; Thomas K Houston; U Shanette Granstaff; Theodore M Johnson; Leslye C Pennypacker; K Sue Haddock; John M Painter; Jessie M Spencer; Thomas Hartney; Kathryn L Burgio Journal: J Gen Intern Med Date: 2014-06 Impact factor: 5.128
Authors: Katrina J Lin; Andrea Ching; Kyle P Edmonds; Eric J Roeland; Carolyn Revta; Joseph D Ma; Rabia S Atayee Journal: J Palliat Med Date: 2015-06-24 Impact factor: 2.947
Authors: Robert Gramling; Elizabeth Gajary-Coots; Susan Stanek; Nathalie Dougoud; Heather Pyke; Marie Thomas; Jenica Cimino; Mechelle Sanders; Stewart C Alexander; Ronald Epstein; Kevin Fiscella; David Gramling; Susan Ladwig; Wendy Anderson; Stephen Pantilat; Sally A Norton Journal: BMC Palliat Care Date: 2015-08-19 Impact factor: 3.234
Authors: J Centofanti; M Swinton; J Dionne; A Barefah; A Boyle; A Woods; M Shears; D Heels-Ansdell; D Cook Journal: BMJ Open Date: 2016-03-31 Impact factor: 2.692